Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-27
2006-06-27
Owens, Amelia A. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S122000
Reexamination Certificate
active
07067528
ABSTRACT:
Hydrates of N-[1-butyl-4-[3-[3-(hydroxy)propoxy]-phenyl]-1,2-dihydro-2-oxo-1,8-naphthyridin-3-yl]-N′-(2,6-diisopropyl-4-aminophenyl)urea hydrochloride of the formula:are quite excellent in stability than amorphous one and are more preferable for medicaments.
REFERENCES:
patent: 5843957 (1998-12-01), Muraoka et al.
patent: 6420381 (2002-07-01), Muraoka et al.
patent: 0842933 (1998-05-01), None
patent: 0947515 (1999-10-01), None
patent: 1 086 948 (2001-03-01), None
patent: 1104763 (2001-06-01), None
Ban Hitoshi
Muraoka Masami
Ohnuma Satoshi
Birch & Stewart Kolasch & Birch, LLP
Owens Amelia A.
Sumitomo Pharmaceuticals Co. Ltd.
LandOfFree
1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3690359